主观认知衰退的老年人的艺术疗法和认知功能:一个网络元分析协议
Qian Liu1, Fang Wang1, Lixia Tan1
1Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.
BMJ open
|April 20, 2024
概括
这项研究审查了对老年人主观认知衰退的艺术疗法. 它旨在确定最有效的艺术疗法来改善认知功能并降低痴呆风险.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 主观认知衰退 (SCD) 是轻度认知障碍和痴呆症的先驱,给老年人,照顾者和社会带来了重大挑战.
- 在全球范围内,SCD的患病率正在增加,需要有效的干预措施来支持老年人群的认知健康.
- 艺术疗法正在成为一种有前途的非药物疗法,用于认知增强.
研究的目的:
- 系统地审查和综合来自随机对照试验的各种艺术疗法对60岁及以上的主观认知衰退的个体有效性的证据.
- 识别和排名最有效的艺术疗法干预措施,以改善这一群体的认知功能.
- 为临床医生和政策制定者提供基于证据的建议,关于SCD的艺术治疗.
主要方法:
- 将对8个电子数据库 (如PubMed,Web of Science) 进行全面搜索,以查找2013年1月至2023年12月期间发表的随机对照试验.
- 包括的研究将侧重于艺术疗法 (音乐,绘画,舞蹈等). 在60岁以上的SCD参与者中,认知功能是主要结果.
- 将进行数据提取,偏差风险评估 (Cochrane工具),证据质量评估 (GRADE),并进行双向和贝叶斯网络元分析.
主要成果:
- 该研究将对现有研究进行元分析,比较不同艺术疗法的疗效.
- 基于其提高认知功能的有效性,艺术疗法的排名将使用积累性排名曲线 (SUCRA) 下面的表面来确定.
- 这些发现将突出SCD处理特定艺术模式的相对好处.
结论:
- 这次系统性审查和元分析将提供关键的见解,以了解艺术疗法对老年人主观认知衰退的有效性.
- 这些结果将指导选择最佳的艺术疗法干预措施,以支持认知健康,并可能延迟或预防痴呆症的进展.
- 生成的证据将为临床实践和制定管理认知衰老的指导方针提供信息.
相关概念视频
Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468


